DBV Technologies
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About DBV Technologies
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
/ 
Frequently asked questions
To buy DBV Technologies stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for DBV Technologies by name or ticker, choose the number of shares, and place your order.
The ticker symbol for DBV Technologies is DBV:xpar. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
DBV Technologies has its primary listing on Euronext Paris. You can trade DBV Technologies with a Saxo account, alongside thousands of other stocks worldwide.
Yes, DBV Technologies is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include DBV Technologies as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like DBV Technologies.